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In the Cys loop superfamily of ligand-gated ion channels, a global
conformational change, initiated by agonist binding, results in
channel opening and the passage of ions across the cell membrane.
The detailed mechanism of channel gating is a subject that has lent
itself to both structural and electrophysiological studies. Here we
defined a gating interface that incorporates elements from the
ligand binding domain and transmembrane domain previously
reported as integral to proper channel gating. An overall analysis of
charged residueswithin the gating interface across the entire super-
family showed a conserved charging pattern, although no specific
interacting ion pairs were conserved. We utilized a combination of
conventional mutagenesis and the high precision methodology of
unnatural amino acid incorporation to study extensively the gating
interface of the mouse muscle nicotinic acetylcholine receptor. We
found that charge reversal, charge neutralization, and charge intro-
duction at the gating interface are often well tolerated. Further-
more, based on our data and a reexamination of previously reported
data on -aminobutyric acid, type A, and glycine receptors, we con-
cluded that the overall charging pattern of the gating interface, and
not any specific pairwise electrostatic interactions, controls the gat-
ing process in the Cys loop superfamily.
The Cys loop superfamily of neurotransmitter-gated ion channels
plays a prominent role in mediating fast synaptic transmission. Recep-
tors for acetylcholine (nicotinic ACh receptor, nAChR),2 serotonin
(5-HT3 receptor), -aminobutyric acid (GABA, types A and C recep-
tors), and glycine are known, and the receptors are classified as excita-
tory (cation-conducting; nAChR and 5-HT3) or inhibitory (anion-con-
ducting; GABA and glycine). Malfunctions in these receptors are
responsible for a number of “channelopathies,” and the receptors are
targets of pharmaceutical efforts toward treatments for a wide range of
neurological disorders, including Alzheimer disease, Parkinson disease,
addiction, schizophrenia, and depression (1, 2). The receptors share a
common architecture, are significantly homologous, and are known to
have evolved from a single ancestral gene that coded for an ACh
receptor.
The gatingmechanism for theCys loop superfamily is one of themost
challenging questions in molecular neuroscience. At issue is how the
binding of a small molecule neurotransmitter can induce a structural
change in a large, multisubunit, integral membrane protein sufficient to
open (gate) a previously closed ion channel contained within the recep-
tor (3, 4). All evidence indicates that the neurotransmitter-binding site
is quite remote (50–60 Å) from the channel gate, the region that blocks
the channel when the neurotransmitter is absent and thatmustmove to
open the channel.
The quest for a gating mechanism has been greatly aided by several
recent structural advances. First, crystal structures of the soluble acetyl-
choline-binding protein (AChBP) (5–7), which is homologous to the
extracellular domain of the nAChR and, by extension, othermembers of
the superfamily, provide a good sense of the layout of the agonist-bind-
ing site and its relationship to the rest of the receptor. Second, continued
refinement of cryo-EM images of the Torpedo nAChR by Unwin and
co-workers (8–10), incorporating insights gained from the AChBP
structure, has produced a full atomic scale model (Protein Data Bank
code 2BG9) of the nAChR. It is important to appreciate from the outset
that 2BG9, although heuristically quite valuable, is not a crystal struc-
ture of the nAChR. It is a model built from low resolution data and
homology modeling. Nevertheless, it represents a substantial advance
for the field, and all modern attempts to obtain molecular scale infor-
mation on the structure and function of Cys loop receptors must con-
sider this as a starting point.
The full 2BG9model of the nAChR (10) immediately suggested ways
in which the agonist-binding site could couple to the transmembrane
region and thus initiate gating. As summarized in Fig. 1, loops 2, 7, and
9 from the AChBP structure are oriented toward the transmembrane
region, and indeed, in 2BG9 these loops make contacts with parts of the
transmembrane domain. Note that loop 7 is the eponymous Cys loop.
The transmembrane region consists of four -helices per subunit,
labeled M1–M4. It is accepted that M2 lines all or most of the channel.
Helix M1 extends out of the transmembrane region toward the extra-
cellular domain, creating a segment termed pre-M1. Although M4 is
somewhat separated from the rest of the protein in 2BG9, recent mod-
eling studies produce a more compact structure in which M4 is more
intimately involved (11). In particular, theC terminus ofM4, a regionwe
will term post-M4, can contact the extracellular domain. A key struc-
ture is theM2–M3 loop, a short connector between the two transmem-
brane helices. Topological considerations have long placed this loop at
the interface between the transmembrane and extracellular domains.
That expectation was resoundingly confirmed by Protein Data Bank
code 2BG9, andmanyworkers have anticipated that this loop could play
an important role in gating. Indeed, recent work (12) has established
that a key proline at the apex of the M2–M3 loop provides the confor-
mational switch that gates the channel in the 5-HT3 receptor.
Several groups have attempted to identify key interactions in the
interface between the extracellular domain and the transmembrane
domain, and we discuss some of these results below. This interface
contains a number of charged residues, and most efforts have focused
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on these, attempting to find crucial electrostatic interactions that regu-
late gating. Specific hydrophobic interactions have also been proposed
(9, 13). Several interacting pairs have been identified in various recep-
tors (14, 15), and specific gating models based on critical electrostatic
interactions have been proposed (16–19).We note from the start, how-
ever, the curious fact that none of the proposed interactions is conserved
across the superfamily. We have been puzzled by the notion that in this
closely related family of receptors, themechanismof action of the essen-
tial function of the receptors seems to vary from system to system.
In the present work we argue that specific, pairwise electrostatic
interactions at the interface between the transmembrane and extracel-
lular domains are not critical to gating. Rather, we argue it is the global
charging of this region and the network of interacting ionic residues that
are critical to receptor function. We present an overall analysis of
charged interfacial residues in the Cys loop superfamily, extensive
mutagenesis studies of potential electrostatic interactions in the
nAChR, and a reconsideration of previously published data on other
receptors to support the model. From such an analysis, a more nearly
unified, but less precise, image of the gating mechanism in the Cys loop
superfamily emerges.
MATERIALS ANDMETHODS
Mutagenesis and mRNA Synthesis—The mRNA that codes for the
muscle type nAChR subunits (, , , and ) was obtained by lineariza-
tion of the expression vector (pAMV) with NotI, followed by in vitro
transcription using the mMessage mMachine kit purchased from
Ambion (Austin, TX). The mutations in all subunits were made follow-
ing the QuickChange mutagenesis protocol (Stratagene).
Electrophysiology and Data Analysis—mRNAs of , , , and  sub-
units were mixed in the ratio of 2:1:1:1 and microinjected into stage VI
oocytes of Xenopus laevis. Electrophysiology recordings were per-
formed 24–48 h after injection in two-electrode voltage clamp mode
using the OpusXpress 6000A (Molecular Devices Axon Instruments).
The holding potential was60mVand agonist was applied for 15 s (20).
Acetylcholine chloride and succinylcholine chloride dihydrate were
purchased from Sigma. All drugs were diluted to the desired concentra-
tionswith calcium-freeND96 buffer. Dose-response datawere obtained
for at least eight concentrations of agonists and for a minimum of five
oocytes.Mutants with Imax equal to or greater than 100 nAwere defined
as functional. EC50 and Hill coefficients were calculated by fitting the
dose-response relation to the Hill equation. All data are reported as
mean S.E.
If saturation was not reached at 1000 M concentrations of acetyl-
choline, the EC50 value could not be calculated. For two mutations,
V46A and V46T, a secondmutation was incorporated at the 9 posi-
tion of the  subunit (L251S). This mutation is known to reduce the
wild type EC50 to 1.2 M (21). The EC50 of the double mutant was then
determined as described. For scatter plots (supplemental Figs. i–iii) the
EC50 value of the double mutant was multiplied by 41.7 (50/1.2) to get a
corrected EC50 value. The corrected EC50 value was used for the linear
regression analysis.
EC50 values for succinylcholine were measured in the same manner.
Maximal currents elicited by acetylcholine Imax(acetylcholine) and by succinyl-
choline Imax(succinylcholine) weremeasured sequentially at saturating concen-
trations on the same cells. The ratio of Imax(succinylcholine)/Imax(acetylcholine)
was calculated for each cell and is reported as mean S.E.
Unnatural Amino Acid Suppression—The preparation of the unnat-
ural amino acid O-methylthreonine is described elsewhere (21).
O-Methylserine was purchased from Sigma and was protected and acti-
vated as described (22). Unnatural amino acids were conjugated to the
dinucleotide dCA and ligated to the truncated 74-nucleotide tRNA.The
aminoacyl tRNA was deprotected by photolysis immediately prior to
co-injection with mRNA containing an amber (TAG) stop codon at the
site of interest. Negative and positive controls were employed as
reported previously (20).
Bungarotoxin Binding and Western Blotting—48–72 h after injec-
tion, oocytes were prewashed with calcium-free ND96 buffer with 1
mg/ml bovine serum albumin, then transferred to the same buffer with
the addition of 10 nM 125I--bungarotoxin (PerkinElmer Life Sciences),
and incubated for 1 h at room temperature (23). Oocytes were then
washed four times and counted individually in a gamma counter.
Oocytes injected with 50 nl of water were used to determine back-
ground. Mutants with more than five times the background reading are
regarded to have sufficient expression.
In order to detect  subunit incorporation for several mutants, anHA
tag (hemagglutinin epitope) was incorporated at the C terminus in the 
subunit (position 497). 24–48 h after injection, 10–20 oocytes were
incubated in hypotonic solution (5 mMHEPES, 5 mMNaCl) for 10 min,
and the vitelline/plasma membranes were then isolated by physical dis-
section and centrifugation (24). The pelleted membranes were resus-
pended in 5l of 2 SDS loading buffer, and SDS-PAGEwas performed
in 10% Tris-Cl ReadyGels (Bio-Rad). The samples were subjected to
Western blot analysis using the anti-hemagglutinin antibody and visu-
alized using an ECL detection kit (Amersham Biosciences).
RESULTS
Electrostatics at the Gating Interface—For the purposes of discussion
and analysis, we have defined a “gating interface” between the extracel-
lular domain and the transmembrane domain. It is comprised of the
following six segments: three from the extracellular domain (all or parts
of loops 2, 7, and 9) and three from the transmembrane domain (pre-
M1, M2–M3, and post-M4). The precise residues considered are given
in TABLE ONE. Unless otherwise noted, we will use the residue num-
bering system accepted for the nAChR 1 subunit. The selection crite-
rion for the gating interface was geometric; only residues that could
reasonably be considered to experience ameaningful electrostatic inter-
action with another component of the gating interface were included.
Because of the low resolution of the nAChR structure and the further
uncertainty introduced by extrapolating to other Cys loop receptors,
precise distance constraints were not applied. Rather, as illustrated in
Fig. 1, we chose a contiguous band of residues in the region where the
extracellular and transmembrane domains meet. Some leeway must be
given in selecting possible interactions, as residues that are not in direct
contact in 2BG9 could become so on transit from the closed state to the
open state or going from one receptor to another.We recognize there is
some arbitrariness to this assignment, but our studies suggested that
extending the definition further out from the interface did not signifi-
cantly impact the analysis. We will refer to the extracellular component
(from loops 2, 7, and 9) and the transmembrane component (from pre-
M1, M2–M3, and post-M4) when discussing the gating interface.
To search for patterns of charged residues, we considered the
sequences of 124 subunits from the Cys loop superfamily, 74 cationic
and 50 anionic channel subunits (see the Supplemental Material).
TABLE ONE shows 22 representative subunits, 11 cationic (excitatory)
channels and 11 anionic (inhibitory) channels, and also serves to define
the various segments. TABLE TWO summarizes the analysis of the full
collection of the 124 subunits. Shown for each segment of the interface
are the number of cationic residues (Lys and Arg), the number of ani-
onic residues (Asp and Glu), the net charge (Z), and the number of
charged residues (N).
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Although there is some variation, the typical gating interface contains
47 residues: 18 in the extracellular component and 29 in the transmem-
brane component. On average, 11.1 or 24% of these residues are
charged. This is not significantly different from expectation based on
the overall frequencies of occurrence of Asp, Glu, Arg, and Lys in pro-
teins (July, 2004, Swiss Protein Database). Most of the residues of the
gating interface are or can be easily imagined to be water-exposed to
some extent; therefore, this global result is not surprising. Of the 11
charged residues found in the gating interface, only two are universally
conserved, Asp-138 and Arg-209. So, although all Cys loop receptors
have a large number of ionic residues in the gating interface, their loca-
tions and absolute charges are variable.
Although the two components of the gating interface do not have the
same number of amino acids, the total number of charges is essentially
the same (5.7 versus 5.5) for the two. There is, however, a dramatic
difference in the net charge of the two components. The extracellular
component has an overall negative charge, averaging3.9 over the 124
subunits considered. The transmembrane component has an overall
positive charge, averaging 2.3. Thus, there is a global electrostatic
attraction in the interface, holding together the extracellular compo-
nent and the transmembrane component. This interfacial electrostatic
interaction is not created by simply putting anions in the extracellular
component and cations in the transmembrane component; typically,
there are one cationic and five anionic side chains in the extracellular
component but four cationic and two anionic side chains in the trans-
membrane component. We propose that it is the balance among all
these charges that controls receptor function. With all these charges
packed into a fairly compact space, we felt it more reasonable to con-
sider a network of electrostatic interactions, rather than emphasizing
any particular charged pair, as discussed below.
There is variability in the charging pattern. Considering only GABAA
subunits, 1 shows Z6 in the extracellular component and Z4
in the transmembrane component. In contrast, the 4 subunit shows
Z4 in the extracellular component and Z2 in the transmem-
brane component. Despite the smaller Z values, the 4 subunit actually
has more ionic residues overall than 1 (n 16 versus 14).
Looking more closely, it is clear that loop 2 carries the most negative
charge per residue, followed by loop 7. The largest net positive charge is
associated with pre-M1. The total number of charges (N) is slightly
larger for the inhibitory channels (average of 11.8 versus 10.7). The
“additional charge” is usually cationic, as the net charge is slightly more
positive for the inhibitory channels (1.1 versus1.9).
We propose that Cys loop receptors can function as long as the essen-
tial features of the electrostatic network are intact. As shown below,
mutations that alter the charge balance are often well tolerated, appar-
ently because they can be absorbed by the larger collection of charges. In
fact, full charge reversals (replacing a plus with aminus or vice versa) are
often quite acceptable. It appears that the important thing is to have a
number of charges in this region, rather than any specific interaction.
Studies of the Muscle-type nAChR  Subunit—We have evaluated a
number of residues in the gating interface by both conventional
mutagenesis and unnatural amino acid mutagenesis (25). Many muta-
tions aremeant to parallel studies in other receptors, but as noted above,
conservation is not strong across the family. We studied the embryonic
mouse muscle nAChR with a subunit composition of (1)21. This
receptor shows extremely high homology with and is thus directly com-
parablewith theTorpedo receptormodeled by 2BG9.A goal of this work
was to conduct an extensive survey of the gating interface, complement-
ing the statistical analysis presented above. As such, we report the
results of two-electrode voltage clamp determinations of EC50, rather
than the more time-consuming patch clamp studies of single channel
behaviors. Because EC50 is a measure of channel function, it reflects
contributions from agonist binding and gating. However, the residues
studied are not part of the agonist-binding site and so seem unlikely to
TABLE ONE
Selected sequences in the gating interface, highlighting cationic (italic) and anionic (boldface) residues
The abbreviations used are as follows: Tor, nAChR fromTorpedo californica; nACh, nicotinic ACh receptor; 5-HT3A, 5-HT3 receptor, typeA. All sequences were
from human receptors except Tor and nACh 1, 1, , , which were from mouse muscle.
Loop 2 Loop 7 L9 Pre-M1 M2–M3 linker Post-M4
Tor  DEVNQI IIVTHFPFDQ EW MQIRP STSSAVPLIGKY FAGRLIELSQEG
Tor  NEKIEE IKVMYFPFDW QW IQRKP ETSLSVPIIIRY FLDASHNVPPDN
Tor  NEKEEA IAVTYFPFDW EW IQRKP ETSLNVPLIGKY FLTGHFNQVPEF
Tor  KETDET INVLYFPFDW EW IRRKP ETALAVPLIGKY FVMGNFNHPPAK
nACh 1 DEVNQI IIVTHFPFDE EW MQRLP STSSAVPLIGKY FAGRLIELHQQG
nACh 1 NEKDEE IQVTYFPFDW QW IRRKP ETSLAVPIIIKY FLDATYHLPPPE
nACh  NEREEA ISVTYFPFDW EW IQRKP ETSQAVPLISKY FLMAHYNQVPDL
nACh  KEVEET ISVTYFPFDW EW IRRKP ATSMAIPLVGKF FLQGVYNQPPLQ
nACh 4 DEKNQM IDVTFFPFDQ EW IRRLP STSLVIPLIGEY FLPP--WLAGMI
nACh 7 DEKNQV IDVRWFPFDV EW MRRRT ATSDSVPLIAQY LMSAPNFVEAVS
5HT3A DEKNQV LDIYNFPFDV EW IRRRP ATAIGTPLIGVY VMLWSIWQYA--
GABA 1 SDHDME MHLEDFPMDA QY LKRKI KVAYATAM-DWF LNREPQLKAPTP
GABA 2 SDTDME MHLEDFPMDA QY LKRKI KVAYATAM-DWF LNREPVLGVSP-
GABA 3 SDTDME MHLEDFPMDV QY LKRKI KVAYATAM-DWF VNRESAIKGMIR
GABA 4 SDVEME MRLVDFPMDG QY LRRKM KVSYLTAM-DWF LSKDTMEKSESL
GABA 5 SDTEME MQLEDFPMDA QY LKRKI KVAYATAM-DWF LNREPVIKGAAS
GABA 6 SDVEME MRLVNFPMDG QY LQRKM KVSYATAM-DWF LSKDTMEVSSSV
GABA 1 SEVNMD MDLRRYPLDE QF LKRNI KIPY-VKAIDIY VN----------
GABA 2 SEVNMD MDLRRYPLDE QF LKRNI KIPY-VKAIDMY VN----------
GABA 3 SEVNMD MDLRRYPLDE QF LKRNI KIPY-VKAIDMY VN----------
Gly-1 AETTMD MDLKNFPMDV QF LERQM KVSY-VKAIDIW KIVRREDVHNQ-
Gly-2 TETTMD MDLKNFPMDV QF LERQM KVSY-VKAIDIW KIIRHEDVHKK-
44 49 130 139 175 207 211 266 277 426
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contribute directly to binding. Furthermore, we show that representa-
tive mutations in the gating interface alter the relative efficacy of succi-
nylcholine, a partial agonist of the mouse muscle nAChR (26), support-
ing a change in the gating of the mutants (14, 27). In addition, we
recently showed that a range ofmutations of a key proline at the heart of
the gating interface in the M2–M3 loop of the 5HT3A receptor signifi-
cantly affected EC50 values but did not alter the binding properties of the
receptor, establishing a role in gating (12). Extensive mutagenesis stud-
ies by Auerbach and co-workers (28) on loops 2 and 7 show that muta-
tions of the sort considered here affect the gating equilibrium. As such,
we concluded that the most reasonable interpretation of the changes in
EC50 values reported here is that they reflect alterations in channel
gating behavior.
Our primary focus has been on the  subunits, as these make the
largest contribution to the agonist-binding site and are thought to play
a prominent role in the gating mechanism (29). In this section all muta-
tions occurred in both copies of themousemuscle subunit; the results
are given in TABLE THREE. In a subsequent section we will consider
the non- subunits.
The 2BG9 model features a particularly intimate interfacial interac-
tion, that between Val-46 on loop 2 and a portion of the M2–M3 loop
(9). A “pin-into-socket” arrangement was proposed, ascribing a critical
gating role to Val-46. Although it was immediately appreciated bymany
workers that Val-46 is not conserved in the Cys loop superfamily, the
proposal merited investigation. Studies by Harrison and co-workers
(13) on analogous residues in the GABAA 1 and 2 subunits and the
glycine receptor 1 subunit (the residue is His, Val, and Thr, respec-
tively) provided no support for the pin-into-socket proposal.
We have explicitly evaluated Val-46 in the nAChR (TABLE THREE).
We wished to determine whether a precise geometrical arrangement of
the sort implied by a pin-into-socket interactionwas essential for proper
receptor function. Not surprisingly, the V46A mutation was substan-
tially deleterious, whereas the more subtle V46I mutant showed near
wild type behavior.
An advantage of the unnatural amino acid methodology is that it
allows subtle stereochemical issues to be probed. If the side chain of Ile
at position 46 points into a well defined pocket, one might anticipate
that the isomeric allo-Ile, in which the side chain methyl and ethyl
groups swap position relative to Ile, would show a significantly different
interaction. In the event, the difference between Ile and allo-Ile is insig-
nificant (TABLE THREE). The unnatural amino acid O-methylthreo-
nine (OMe-Thr) is isosteric with Ile but inserts a more polar O in place
of a CH2 group (21). This subtle change is deleterious, raising the EC50
3-fold. The isomeric OMe-allo-Thr introduces a stereochemical
swap that parallels the Ile/allo-Ile pair (Scheme 1). The difference
between OMe-Thr and OMe-allo-Thr is 5-fold, corresponding to 1
kcal/mol at room temperature. This suggests that perhaps the side chain
of position 46 is in a sterically well defined pocket, but one that can only
be probed by polar oxygen atoms and not by hydrophobic groups such
as CH2.
Replacing Val-46 with much more polar groups like Thr (essentially
isosteric to Val) and the anionic Asp and Glu seriously compromises
receptor function. Radiolabeled -bungarotoxin binding studies show
that V46D and V46E channels are expressed in large enough quantities
to detectmacroscopic currents, but electrophysiology studies showonly
small (	300 nA) currents at 1 mM ACh, suggesting a shift to a much
higher EC50. Most surprisingly, however, the cationic residues Arg and
Lys produce, in the first case, only amodest rise in EC50 values, although
the V46K mutant gives an EC50 value 50-fold below wild type. The
V46K mutation of the nAChR 1 subunit produces a loop 2 pattern
TABLE TWO
Charge characteristics of the gating interface
The abbreviations used are as follows: indicates number of cationic residues
(Lys and Arg); indicates number of anionic residues (Asp and Glu); Z indi-
cates overall charge; and N indicates the number of ionic residues.
  Z N
Loop 2 0.5 2.3 1.8 2.8
Loop 7 0.4 1.9 1.5 2.4
Loop 9 0.0 0.5 0.5 0.5
Pre-M1 2.3 0.1 2.2 2.3
M2–M3 1.0 0.8 0.2 1.8
Post-M4 0.6 0.7 0.1 1.3
Extracellular 0.9 4.8 3.9 5.7
Transmembrane 3.9 1.6 2.3 5.5
Gating interface 4.8 6.4 1.6 11.1
FIGURE 1. Views of the gating interface. Struc-
ture is the fullmodel of an subunit of the Torpedo
nAChR developed by Unwin (10) (Protein Data
Bank code 2BG9). Regions of the gating interface,
as defined in text, are color-coded. A, ribbon dia-
gram, also including pairwise interactions from
various studies that have been proposed to con-
tribute to the gating mechanism. Even though
they are from different receptors and could be
important in different states of the receptor, they
aremapped onto the Torpedo structure to provide
some sense of relative spatial relationships. Dis-
tances range from6 to20Å. Interactions are as
follows: 1, Asp-138 to Lys-276 of muscle  nAChR;
2, Asp-138 to Arg-429 of muscle  nAChR; 3,
Asp-57 to Lys-279ofGABAA1 subunit; 4,Asp-149
to Lys-279 of GABAA1 subunit; 5, Lys-215 to Asp-
146 of GABAA 2 subunit; 6, Lys-215 to Asp-139 of
GABAA 2 subunit; and 7, Lys-215 to Asp-56 of
GABAA 2 subunit. Interactions 1, 2, 4, and 5 all
involve the same highly conserved Asp residue in
loop 7. See text for discussion of these interac-
tions. B, same view as A but with gating interface
residues in space filling. C, view in B rotated 180°
around vertical axis.
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equivalent to those of the 7 and 4 nicotinic and 5-HT3 serotonin
receptors, and so perhaps it is not surprising that it can be tolerated.
We have sought a correlation between various physicochemical
properties of the mutant side chains and the mutant EC50 values at
Val-46 (supplemental Fig. i), and we found that there was no apparent
correlation to the side chain hydrophobicity (30, 31) or size (32, 33).
Auerbach and co-workers (28) previously reported single channel
recordings on several mutations at Val-46, and a very rough tendency
was observed that more polar side chains have smaller gating equilib-
rium constants. However, the new mutations that we have studied,
V46K and V46R, do not follow this pattern. Our results suggested that
although the side chain of Val-46 may be docked into a sterically well
defined pocket as implied by the pin-into-socket mechanism, a full
description of the role Val-46 plays in gating is more complicated.
As noted above, loop 2 is highly charged across the Cys loop super-
family, with an overall negative charge. As others have done in different
receptors within the superfamily, we have evaluated some of these
charged residues. Position 45 is very highly conserved as anionic (Asp or
Glu), and our studies of Glu-45 in themuscle subunit are summarized
in Fig. 2. Quite surprisingly, we find that full charge reversal (E45K or
E45R) substantially lowers EC50. Substitution by a neutral but polar
residue (E45Q or E45N) also lowers EC50, whereas conversion to a
hydrophobic residue gives a small effect, raising EC50 if anything. The
logarithms of the mutant EC50 at Glu-45 were plotted against the phys-
icochemical properties of themutant side chains as done forVal-46, and
no apparent correlation was found (supplemental Fig. ii).
Asp-44 is conserved in nicotinic  subunits, and position 44 is gen-
erally a polar residue in other nicotinic subunits and other receptors.
TABLE THREE
Mutations in the nAChR  subunits
EC50 values are shown inM. The abbreviations used are as follows: NF, nonfunctional, no response to applied ACh but surface expression of receptor confirmed
by -bungarotoxin binding; LE, functional, responses to applied ACh are seen but are too weak to obtain EC50; NS, no signal, no response to applied ACh, surface
expression not independently verified; NE, no expression, as judged by lack of -bungarotoxin binding.
Mutant EC50 nH Mutant EC50 nH
Wild type 50 2 1.6 0.1 D138K/R429D 50 3 1.45 0.1
D44K 14.3 0.6 1.4 0.1 D138R/R429E LE
D44N 20 4 0.80 0.08 D138E/R429K 63 9 1.31 0.2
E45A 210 20 1.1 0.1 D138K/K276D/R429D 67 10 1.03 0.2
E45W 117 7 1.3 0.1 K276D 45 6 1.39 0.2
E45V 49 4 1.9 0.2 K276E 38 2 1.28 0.07
E45D 19.2 0.5 1.4 0.1 K276D/R429D 51 3 1.52 0.1
E45N 6.3 0.1 1.4 0.1 R429D 57 5 1.46 0.1
E45K 6.5 0.3 1.4 0.1 R429E 69 5 1.29 0.09
E45Q 1.9 0.1 1.3 0.1 R429K 83 4 1.48 0.09
E45R 1.6 0.1 1.0 0.1 R429A 90 4 1.48 0.08
V46A 1000 1.6 0.1 S266K 62 6 1.54 0.2
V46I 59 7 1.1 0.1 T267A 36 5 1.94 0.4
V46allo-I 48 2 1.7 0.1 T267D 24 2 1.21 0.1
V46OMeT 169 9 1.4 0.1 T267K 26 2 1.35 0.05
V46OMe-allo-T 32 2 1.5 0.1 T267OMeT 200 10 1.37 0.1
V46T 1000 1.4 0.1 S268D 0.59 0.02 1.82 0.09
V46K 0.94 0.07 1.5 0.1 S268E 0.18 0.01 1.56 0.1
V46R 120 10 1.4 0.1 S268K 7.5 1 1.36 0.2
V46D 1000 S269D 12 0.5 1.56 0.08
V46E 1000 S269E 0.08 0.01 1.34 0.2
E45K/V46D 1000 S269K 9 0.6 1.22 0.08
E45K/V46E 1000 S269OMeS 23 2 1.79 0.3
E45R/V46D NE R209A NE
E45R/V46E NE R209D NF
D138A NF R209E NF
D138R NF R209K 18 1 1.66 0.2
D138K NF D138K/R209D NF
D138S NF D138R/R209D NS
D138N NF E175R 120 7 1.35 0.08
D138E 28 2 1.45 0.1 E175R/R209E NS
D138K/K276D 66 10 1.01 0.1
SCHEME 1
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Although the Asp-44 side chain points in the opposite direction to the
Glu-45 side chain in 2BG9, the mutation pattern is similar. Both charge
reversal and introducing a neutral but polar side chain lower EC50
values.
Asn-47 in loop 2 of the nAChR  subunit aligns with Asp-57 of the
GABAA 1 subunit, which, as discussed below, has been proposed to
experience important electrostatic interactions (15). Auerbach and co-
workers (28) have studiedmutations at this site in the nAChR, including
extensive single channel measurements. Auerbach and co-workers (28)
found that N47K shows a decrease in EC50 values, but N47D shows an
increase. As noted above, the single channel studies of this and other
loop 2 residues by Auerbach and co-workers (28) establish a role in
setting the gating equilibrium for residues in this region.
Thus, at four consecutive residues in loop 2, Asp-44, Glu-45, Val-46,
and Asn-47, introducing a positive charge lowers EC50. At Asn-47 and
Val-46 it has also been shown that introducing a negative charge has the
opposite effect. These various side chains point in quite different direc-
tions in 2BG9. Although is it possible that all these side chains make
specific electrostatic contacts that are being modulated in similar ways
by the mutations introduced, we conclude instead that it is the global
negative charge of loop 2, not any specific pairwise interaction, that is
essential to proper receptor function.
Asp-138 on loop 7 is completely conserved in the Cys loop superfam-
ily. Others have investigated this site in other receptors (14, 15, 28). In
the nAChR  subunit, charge reversal at this site incapacitates the
receptor. Both D138K and D138R give nonfunctional receptors in that
no response to ACh is seen, but labeling with the radioactive -bunga-
rotoxin shows that properly assembled receptors have reached the sur-
face. Furthermore, milder disruptions of Asp-138 such as mutation to
Asn, Ala, or Ser also give nonfunctional receptors. The charge conserv-
ing mutation D138E, however, gives near wild type behavior. All evi-
dence shows that a negative charge at this site is essential to form a
functional receptor.
A classic test for a specific ion pair interaction is the charge swapping
experiment; i.e. if Asp-138 experiences an electrostatic interaction with
a specific cationic residue, then the nonfunctional mutant often can be
“rescued” by converting the cationic partner to an anion. In the nAChR,
we considered two possible cationic partners to Asp-138: Lys-276 on
M2–M3 and Arg-429 on post-M4 (pairwise interactions 1 and 2,
respectively, in Fig. 1A). Both are fairly close to Asp-138 in 2BG9. Most
interestingly, the nonfunctional D138K mutant can be returned to
essentially wild type behavior by combination with either K276D or
R429D (TABLE ONE and Fig. 3). This suggested that perhaps the 138/
276/429 grouping should be considered as a charge triad, rather than a
collection of pairwise interactions. As such, we evaluated all eight pos-
sible charge combinations for these three residues. The wild type is
// (138/276/429); the nonfunctional D138K/D138R mutants are
//. The described double mutants that rescue the channel are
// and //. In fact, all seven combinations other than the
//mutant give near wild type behavior (Fig. 3). It appears that the
138/276/429 grouping can compensate for a range of charge patterns, as
long as // is avoided. It may seem surprising that the //
combination is viable. If these residues are physically close, we can
anticipate that having three negative charges in proximity would alter
the effective pKa of one ormore residues. This could lead to protonation
of a carboxylate side chain and lessening of the electrostatic interaction.
It is also possible that one or more water molecules mediate the inter-
actions among 138/276/429. As will be discussed below, Asp-138
appears to be associated with a different charge triad in the GABAA
receptor.
Position 276 is conserved as a charged residue, either positive or
negative, in the majority of ACh receptor subunits but not in other
members of the superfamily. Position 429 is often but not always
charged, being anionic inGABA receptors, cationic in glycine receptors,
but neutral in nicotinic non- subunits. Thus, the triad considered here
is most likely specific to the nAChR  subunit. Residue 429 is on post-
M4, and theM4 transmembrane helix is the furthest separated from the
rest of the protein. In 2BG9, the C terminus of M4 is roughly 10 Å from
the tip of loop 7. However, as mentioned above, computational studies
moveM4 closer to the rest of the protein and explicitly identify contacts
between M4 and loop 7 (11). Also, it has been proposed from the com-
putational work that during channel opening, M4 of the 7 receptor
moves closer to the other three transmembrane helices. In the linear
free energy relation analysis by Auerbach and co-workers (34), the
movement of an M4 precedes that of M2. Based on the observations
reported here, we conclude that in the open state of the nAChR, Arg-
429 on post-M4 is one of the electrostatic interaction partners of
Asp-138.
FIGURE 2.Avariety ofmutations atGlu-45 arewell tolerated.Charge neutralization
(Asn and Gln) and charge reversal (Lys and Arg) both lower EC50 values substantially,
although mutations to hydrophobic residues (Ala, Trp, and Val) leave EC50 values little
changed. A, dose-response curves. B, ratios of mutant to wild type (WT) EC50 values
plotted for comparison.
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We have also studied other positions of the M2–M3 linker. Four
consecutive hydroxyl-containing residues, STSS, appear at positions
266 to 269 of the nAChR 1 subunit. Various mutations at Ser-266 and
Thr-267 do not shift EC50 significantly (TABLE THREE). This includes
mutations that would typically be considered fairly dramatic, in that a
neutral residue is changed to an ionic residue. AtThr-267, conversion to
a positive charge or a negative charge both result in halving EC50.
Ser at position 269 has been probed previously by Auerbach and
co-workers (35), who reported that an S269I mutation causes an EC50
decrease of 10-fold, mainly by increasing the channel opening rate
constant. Based on this observation, it was proposed that position 269
moves from a polar to a nonpolar environment on channel opening, and
so increasing hydrophobicity should favor the open state and lower
EC50. To probe this further, we incorporated the unnatural amino acid
O-methylserine at position 269, an arguably more subtle way to reduce
polarity than S269I. The mutant channel shows a 2-fold drop in EC50,
consistent with the expectation that an increase in hydrophobicity low-
ers EC50, and the less perturbing Ser/OMeSer has a smaller effect.
Against this background, we were surprised to find that a change in
the opposite direction (introducing either a positive or a negative charge
at 269) also lowers EC50; S269D and S269K show 4–5-fold drops,
whereas S269E shows an astonishing 600-fold drop in EC50. Certainly,
Asp, Glu, and Lys are more polar than Ser, and so these results contra-
dicted the just reached conclusion that hydrophobicity controls the
behavior at position 269. We saw the same pattern for Ser-268; S268D,
S268E, and S268K all show lower EC50 values, with theGlumutant again
showing a very large drop. It is remarkable that at two consecutive sites
in the M2–M3 loop, a region universally accepted to be involved in the
gating transition, a serine can be converted to a cationic or an anionic
residue, and the result is the same, the EC50 drops.
Pre-M1 provides the covalent connection between the extracellular
and transmembrane domains in the primary sequence, and there are
1–4 positive charges in this region throughout the ligand-gated ion
channel family. One Arg (Arg-209 in the nAChR 1 subunit) is com-
pletely conserved. Mutation to glutamine at the analogous arginine in
the glycine receptor 1 subunit causes hyperekplexia, an inherited
channelopathy, and greatly diminishes receptor function (36). Among
all the mutations at this site in the nAChR, only a charge-conserving
mutation, R209K, gave a functional channel; charge reversal mutants
were nonfunctional. In 2BG9, the Arg-209 side chain projects between
Glu-175 on loop 9 and Glu-45 on loop 2. Charge swapping experiments
at this triad, however, show that the nonfunctional mutant R209E can-
not be rescued by either E175R or E45R.
Loop 9 is located close to the transmembrane domain, between
pre-M1 and loop 2. Chimera studies in Cys loop family members have
characterized it as an indispensable contributor to proper channel cou-
pling and functioning (37). In 2BG9 loop 9 has moved significantly
closer to the transmembrane domain compared with the AChBP struc-
ture, suggesting that it is arranged differently when the transmembrane
domain is present. Position 175 is located very close to the transmem-
brane domain and is counted as part of the charged interface. Glu-175 is
conserved in the majority of excitatory channel subunits, although in
inhibitory channels it is frequently replaced by a Gln. Mutation studies
at this site show that a charge reversal increased the EC50 but by a
modest factor.
Studies of the Muscle-type nAChR Non- Subunits—We have evalu-
ated a large number of charged residues in the non- subunits. Our
primary emphasis has been on charge reversal and charge neutralization
mutations (e.g.Glu3 Lys and Glu3Gln). TABLE FOUR summarizes
these data, showing for each site the consequences of charge reversal
and charge neutralization. Again, to facilitate comparisons, we will use
1 subunit numbering conventions in discussing these non- subunits.
Typically, the changes seen in non- subunits are not as dramatic as
those seen in , but some interesting observations can be made. In loop
2, which frequently has a larger number of charged residues (largerN) in
the non- subunits than in , most of the charged residues are fairly
tolerant of substitution, producing changes in EC50 usually 2-fold or
less, in contrast to the 10–30-fold changes often seen in . At almost
every site charge reversal is readily accommodated. Even at the very
highly conserved Glu-45 site, charge reversal/neutralization is generally
tolerated (TABLE FIVE). In fact, the triple mutant E45X in , , and 
gave near wild type behavior for X Gln, Arg, Lys, Asp, Asn, or Val. A
5-fold drop in EC50 is seen for the triple A mutant, although a compa-
rable E45Amutation of the two  subunits leads to a 4-fold rise in EC50
values. Overall, the non- loop 2 regions seem less sensitive to pertur-
bation than . As with the  subunit, efforts to correlate variations in
EC50 with various physicochemical properties of the side chains were
unsuccessful.
FIGURE 3. Charge reversal at Asp-138 of the
nAChR is rescued by charge swap at either of
two sites: Arg-429 (post-M4) and Lys-276 (M2–
M3). A charge triad is examined. Of the eight pos-
sible combinations, seven give nearwild type (WT)
behavior. Only the all-positive triad is deleterious.
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Although D138K gives nonfunctional receptors that can be rescued
by compensating charge-reversal mutations, D138K in  or  subunits
gives functional receptors with no large change in EC50 values (TABLE
FOUR). The D138K mutant gave very low currents in response to
acetylcholine. Similarly, charge reversals in pre-M1 at Arg-208, Arg-
209, or Lys-210 are generally well tolerated in non- subunits. The
Lys-210 to Glu or Glnmutations in  or  subunits produce some of the
largest changes in EC50, showing a 5–10-fold drop in EC50 for charge
reversal/neutralization.
Finally, charge reversal/neutralization is well tolerated throughout
the M2–M3 region in non- subunits. Almost all changes lower EC50
values, but the effects are all less than 3-fold. Apparent exceptions are
the E266K and E266Qmutants, which gave little response to applied
ACh. The previously employed test for surface expression, binding to
-bungarotoxin, was considered less reliable here, because receptors
lacking the  subunit can assemble on the cell surface and bind bunga-
rotoxin. As such, we tested for expression by incorporating an HA
epitope tag at the C terminus of the  subunit and evaluating surface
expression by using aWestern blot. Previously, we have shown that the
high sensitivity of anti-HA antibodies makes this a very sensitive probe
of surface expression (38). For both the E266K and E266Q mutants,
we find strong evidence for the  subunit reaching the cell surface,
indicating that thesemutants do not disrupt folding, assembly, or trans-
port of the receptor (data not shown). Most interestingly, E266R and
E266N mutants do give significant currents, and the EC50 values are
only slightly higher than the wild type receptor.
It is clear that functionally, the non- gating interfaces play a less
important role than the  interfaces. Auerbach and co-workers (35)
concluded that, in the M2–M3 loop, homology in sequence does not
coincide with homology in function, and mutations in the  subunit do
not affect gating, consistent with our observations (34, 39, 40). From a
structural perspective, however, the overall results from studies of
non- subunits highlight the remarkable tolerance of the gating inter-
face. Dozens of charge reversal/neutralization perturbations are well
tolerated, with the most common outcome being a small drop in EC50.
No evidence for highly specific, structurally or functionally important
ion pair interactions is seen.
Studies of a Partial Agonist—To support our contention that
mutations at the gating interface perturb the gating of the receptor
rather than the agonist-binding site, we measured the relative effi-
cacy () of succinylcholine (SuCh), an nAChR partial agonist (26), for
wild type receptor as well as for several representative mutants. The
relative efficacy is defined as the ratio of the maximal current elicited
by the partial agonist to the maximal current elicited by a full agonist
(ACh) (Equation 1).

Imax,PA
Imax,FA

Popen,PA
Popen,FA
(Eq. 1)
Equation 2 shows a highly simplified model of the agonist binding and
receptor gating process.
Rc-|0
A
A
RcA-|0
A
A
RcA2-|0


RoA2 (Eq. 2)
Popen

 
(Eq. 3)
where R is receptor; c is closed; o is open; A is agonist; and  and  are
the opening and closing rate constants, respectively. At saturating doses
of agonist, all the receptors are forced into a diliganded state (RA2), so
differences in Imax for the two agonists are because of differences in
Popen. As such,  reflects the ratio of Popen values for the partial and full
agonists (Equation 1). If a mutation has not altered the gating, but only
the ligand binding of the receptor, the relative efficacies should be iden-
tical for the wild type and mutant receptors (14, 27).
For the wild type nAChR, Popen for ACh is very nearly 1 but Popen for
succinylcholine is only 7.5% that for acetylcholine (  0.075). As a
control, we examined a previously studied mutant known to affect gat-
ing.Mutation of a universally conserved leucine at the 9 position ofM2
to a more polar residue such as serine (L251S) substantially reduces
EC50 values (21, 41, 42). This residue forms part of the hydrophobic gate
of the channel and is quite remote from the agonist-binding site, estab-
lishing it as a gating residue. As shown in Fig. 4, the SuCh  of the
L251S mutant is substantially increased over that of wild type. This
indicates that Popen for SuCh has increased in the mutant, as expected
for a mutation that substantially affects gating.
In the  subunit, the loop 2 mutations E45R and E45Q and the
M2–M3mutation S268E all decrease EC50 more than 25-fold. All three
mutations greatly increase , giving values near 1 (Fig. 4). This indicates
that these mutations ease receptor opening, allowing SuCh to act as a
full agonist. More importantly, the mutation E45V, which has no affect
on EC50, does not alter the  of SuCh. The K210Q mutation in pre-M1
of the  subunit shows only a small increase in . We evaluated this
mutation both in the context of the otherwise wild type receptor and in
receptors that contain the L251S mutation, which moves the EC50
values into a more manageable range. The small change in  at this site
supports the idea that the non- subunits are less of a factor in channel
gating.
TABLE FIVE
Mutations at Glu-45
EC50 values are shown in M.
Glu-45 mutant        triple mutationEC50 nH EC50 nH EC50 nH EC50 nH EC50 nH
Gln 1.9 0.1 1.3 0.1 75 4 1.3 0.1 51 1 1.4 0.04 28 2 1.2 0.1 31 2 1.2 0.1
Arg 1.6 0.1 1.0 0.1 128 4 1.4 0.04 69 2 1.3 0.3 19 1 1.4 0.1 45 4 1.4 0.2
Lys 6.5 0.3 1.4 0.1 144 7 1.5 0.1 95 2 1.4 0.03 25 1 1.5 0.1 79 8 1.1 0.1
Asn 6.3 0.1 1.4 0.1 22 1 1.1 0.04 18 1 1.3 0.1 90 4 1.0 0.03 72 3 1.2 0.05
Asp 19.2 0.5 1.4 0.1 62 4 1.1 0.05 77 4 1.2 0.04 29 2 1.1 0.1 50 3 1.2 0.1
Val 49 4 1.9 0.2 88 4 1.0 0.04 37 0.4 1.2 0.02 34 1 1.3 0.05 38 1 1.1 0.03
Ala 210 20 1.1 0.1 32 3 1.0 0.1 26 1 1.2 0.04 11 1 1.2 0.1 11 0.4 1.2 0.1
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PreviousWork on the GABAA andGlycine Receptors—Several impor-
tant studies of possible electrostatic interactions in Cys loop receptors
have appeared fromHarrison and co-workers (14, 15) and Schofield and
co-workers (18). In each case, a specific electrostatic interaction was
identified bymutagenesis studies, emphasizing charge-reversal/charge-
rescue strategies. Although we do not disagree with the fundamental
observations of these efforts, we feel the results can be reinterpreted in
the context of the charged interface model proposed here.
In the GABAA receptor 1 subunit, Harrison and co-workers (15)
propose ion pair interactions between Lys-279 on theM2–M3 loop and
two aspartates: Asp-57 on loop 2 and Asp-149 on loop 7 (pairwise inter-
actions 3 and 4, respectively, in Fig. 1A). Here we used the GABAA
numbering. The analogous residues in the nAChR  subunit are as
follows: Ser-266, Asn-47, and the previously discussed Asp-138; the
proposed electrostatic interactions are not conserved. In the GABAA
receptor it is proposed that these “specific electrostatic interactions pro-
vide an intramolecular coupling mechanism” for the receptor. The
K279D mutation results in an 10-fold increase in EC50 values. How-
ever, full receptor function is regained when K279D is coupled with
either D57K or D149K. In addition, it is proposed that Asp-149 and
Lys-279move closer to one another during the transition from closed to
open state, presumably strengthening the ion paring interaction.
In Fig. 5, we present these results in the same format as in our discus-
sion of the charge triad of the nAChR given in Fig. 3. Themutation data,
and the generally accepted notion that loop 2 and loop 7 straddle
M2–M3, imply a triangular relationship between Asp-57, Asp-149, and
Lys-279. Thus, the K279D mutation puts three negative charges in an
array, which is apparently unfavorable.What is initially surprising, how-
ever, is that K279D is fully rescued by the single Asp/Lys mutations at
either site 57 or site 149, producing receptors that actually function
“better” (lower EC50) thanwild type. Thismeans that although theD57K
compensatingmutation does rescue the 57279 interaction, 149279 is
still a repulsive AspAsp interaction, and yet the receptor shows EC50
values below wild type. The exact same situation holds with the single
D149Kmutation. Also, if 149 and 279 move closer to each other during
gating, how could a structure in which they are both aspartates (D57K/
K279D) gatemore efficiently thanwild type? If the key interactionswere
Asp-57Lys-279 and Asp-149Lys-279, the highly efficient gating of
theD47K/K279D andD149K/K279D doublemutants would be difficult
to understand.
Wepropose that no specific ion pair interaction influences gating, but
instead a cluster of charges similar to that described in Fig. 3 is impor-
tant. The single K279Dmutation puts three negative charges in a cluster
and that is apparently unfavorable. In contrast, the wild type has a
// pattern (57/149/279), while the double mutants are //
and //. Any pattern of three charges adding up to 1 gives wild
type behavior (or better). Other mutants were also evaluated (Fig. 5).
Apart from// (the original K279Dmutant), the only severely del-
eterious cluster is //0 (K279A), with a charge of 2. Clusters with
three charges that sum to 1 are not overly harmful. The //
mutant (D57K) shows only a 10% increase in EC50, and// (D149K)
is much less than 2-fold higher. Surely these models are not of high
enough precision to interpret such small differences. It seems the
important thing is simply to have a cluster of charges that are not all the
same, with specific ion pairing interactions being nonessential. Note the
parallel behaviors of the 57/149/279 triad in the GABAA 1 subunit and
FIGURE 4.Relative efficacy () of succinylcholine (versusACh) for several variants of
the nAChR.WT,wild type.
FIGURE 5. Analysis of previously published
results for the GABAA receptor 1 subunit (15)
in the same manner as in Fig. 3, suggesting a
charge triad interaction. ND  not determined;
WT, wild type.
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the 138/276/429 triad in the nAChR 1 subunit (recall that nAChR 138
and GABAA 149 are aligned residues). Great variation in the charging
pattern is tolerated, with nonfunctional receptors resulting only from
clusters with very high overall charge.
Evidence for a cluster can also be seen in the GABAA 2 subunit (14).
The mutation K215D (pre-M1; aligns with nAChR 1 Gln-208) is del-
eterious; EC50 goes up 6.1-fold relative to wild type, corresponding to a
penalty of 1.1 kcal/mol. This is substantially rescued by a compensating
the D146K mutation (loop 7; aligns with nAChR 1 Asp-138; pairwise
interaction 5 in Fig. 1A). EC50 is only 1.5-fold higher than wild type,
corresponding to a 0.25 kcal/mol penalty. Thus, 77% ((1.1–0.25)/1.1) of
the K215D penalty is rescued byD146K.However, other charge reversal
mutations in the interfacial region also significantly rescue K215D.
D139K (aligns with nAChR 1 Asp-131; pairwise interaction 6 in Fig.
1A) rescues 64%; D56K (loop 2; aligns with nAChR 1 Ile-49; pairwise
interaction 7 in Fig. 1A) rescues 49%; E147K (aligns with nAChR 1
Gln-139) rescues 29%; andE52K (alignswith nAChR1Glu-45) rescues
25%. Stated differently, the range of EC50 values for the three best rescue
mutants (D146K, D139K, and D56K) is substantially less than 2-fold. It
seems risky to ascribe a special relationship to the 146215 pair. Again,
an image of Lys-215 as presenting a positive charge to a cluster of neg-
ative charges, such that it cannot itself be a negative charge, seemsmore
sensible.
Studies of the glycine receptor from Schofield and co-workers (18)
identified several charged residues on loops 2 and 7 that appeared to be
important for gating. However, no particular pairwise relationships
were uncovered, leading to the conclusion that these residues played a
key role, but not through a “direct electrostatic” interaction.
DISCUSSION
We have defined for the Cys loop superfamily of receptors a gating
interface that is composed of segments from the extracellular domain
and the transmembrane domain that can reasonably be assumed to be
juxtaposed, based on mutagenesis data and the best available structural
information. Analysis of representative subunits from the superfamily
indicates that there are a large number of ionic residues in the interface,
but for the most part their precise locations and particular charges are
not conserved. Many workers, including ourselves, have sought specific
ion pair interactions that exert precise control over the gating process.
However, we have come to believe that, with such a large number of
charges clustered in a fairly compact region, it is not meaningful to
isolate specific ion pairs. Rather, the global charging pattern of the gat-
ing interface is what controls gating. Receptors have evolved to create a
compatible collection of charged residues that allows the receptor to
assemble and also facilitates the existence of and interconversions
among multiple states.
Although specific ionic residues are generally not conserved, overall
charging patterns are.Within the gating interface the extracellular com-
ponent carries a net negative charge, and the transmembrane compo-
nent carries a net positive charge. This creates a global electrostatic
attraction at the interface that maintains the integrity of the receptor as
it transitions from the mostly -sheet, relatively polar extracellular
domain to the -helical, nonpolar transmembrane domain.
Several lines of evidence support this way of thinking about the gating
interface.We have studied a number of mutations that reverse, neutral-
ize, or introduce charges. Typically, these are considered to be dramatic
mutations, and theymight be expected to be disruptive at a functionally
important interface. However, one of the more remarkable features of
the mutagenesis data of TABLES THREE to FIVE is the tolerance of the
gating region to such charge disruptions. In fact, very often the EC50
value is lowered by such strong perturbations. It seems hard to imagine
that dramaticmutations involving the introduction or reversal of charge
just happen to lead to a viable ion pair that is tolerated by the receptor.
Rather, we believe the entire gating interface is tolerant of charge up to
a point. A balancing act is in operation. By distributing a large number of
charges across an interface, it is possible to have movement along that
interface without creating adverse situations of like charges interacting
strongly or a single charge in isolation in a poorly solvated environment.
Consider Thr-267. Introducing charge is not deleterious at this site. In
fact, converting the neutral Thr to a cation (T267K) or an anion
(T267D) has the same effect, i.e. EC50 is halved. It appears that it is the
number of charges that matters and not their particular identities. The
same pattern is seen at Ser-268 and Ser-269. These residues are on the
M2–M3 loop, a region that is universally accepted to be important in
gating in the Cys loop superfamily of receptors (15, 35, 37, 43, 44). Loop
2 always carries a significant negative charge, and we show here that
introducing a positive charge at any of four locations (Asp-44 toAsn-47)
lowers the EC50 value. It thus appears that the negative charge stabilizes
the closed state of the nicotinic receptor by interacting with a positive
region. Based on Protein Data Bank code 2BG9 (8, 9), the M2–M3 loop
seems the likely candidate for the positive region, but again the precise
positioning of residues may be different.
A few charge reversals have been shown to be deleterious, and they
can often be rescued by compensating charge reversals. The universally
conserved Asp-138 is one such residue. In the nAChR 1, the GABAA
1 (15) (where it is Asp-149) and GABAA 2 (14) (where it is Asp-146)
compensating charge reversals can rescue the initial mutant (pairwise
interactions 1, 2, 4, and 5 in Fig. 1A). However, the systems use com-
pletely different residues from apparently very different regions of the
interface. There is certainly no universal pattern, and it appears that
rather than conserving some specific pairwise interaction, it is the global
charging pattern of the trio of residues that is most important. At
another site, Asp-139 ofGABAA2 (14) (Ile-131 of nAChR1), asmany
as five different sites can contribute to compensating a charge reversal,
with a gradation of efficiencies.
We conclude that no one ion pair interaction is crucially important to
gating across the entire Cys loop superfamily; clearly each receptor is
different. However, it may be that there is a consistent mechanism
across the superfamily, but one that does not single out any particular
ion pair. Several groups have suggested that the extracellular domain
and the transmembrane domain change relative positions going from
the closed to the open state. Harrison and co-workers (15) propose that
a residue on loop 7moves closer to a residue onM2–M3 in the GABAA
receptor 1 subunit (Asp-149 and Lys-279, GABAA numbering; pair-
wise interaction 4 in Fig. 1A). The detailed gating model from Unwin
(10) emphasizes differential interactions between loops 2/7 (extracellu-
lar domain) and M2–M3 (transmembrane domain) along the gating
pathway.We have proposed recently (12) that loop 2 and especially loop
7 interact with a specific proline on M2–M3 differentially in the open
and closed states. In order to accommodate the structural rearrange-
ment at the gating interface, the many charges involved must be com-
fortable in the environments provided by both the open and closed
states and must also experience no highly adverse interactions in the
transition state separating the two. With a large number of charges
distributed throughout the interface, the extracellular domain and the
transmembrane domain can slide past one another (or twist or turn or
unclamp . . . ) while maintaining an acceptable network of compensat-
ing charges throughout the process. During the movement, some ion
pair interactions will strengthen and some will weaken, but crucial
on/off interactions seem less critical. There are clearly many ways to
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achieve the proper balance, and each system has evolved an ionic array
that supports the desired gating behavior. The essential mechanism is
universal across the Cys loop superfamily, but the precise details vary
from system to system.
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